Acquired by Euphrates Vascular
Industries BiotechnologyHealth CareMedical DevicePharmaceuticalHeadquarters Regions Midwestern US Founded Date 2008 Founders Francis Creighton, Rogers Ritter Operating Status Active Last Funding Type Venture - Series Unknown Legal Name Pulse Therapeutics, Inc.
Company Type For Profit
Contact Email admin@pulsetherapeutics.com Phone Number (314)787-7475
Pulse Therapeutics is a growing medical technology company headquartered in St. Louis, Mo. The medical developer is advancing the fight against stroke, heart disease, and other conditions with its high-level treatment solutions, which utilize the latest biomedical technology and processes.
Pulse’s signature offering, the MED System, was designed
to harness magnet-based technology to rapidly dissolve blood clots faster than current modalities. This faster rate of delivery of FDA-approved clot-busting medication could dramatically reduce the number of lives lost each year to stroke, heart disease, and other diseases.
This pioneering medical development company was founded by leading physicists Francis “Duke” Creighton and Rogers Ritter. Dr. Creighton, who also serves as Pulse’s chief technical officer, has 20-plus years of expertise in the medical technology industry, specializing in the stroke and cardiovascular sectors. He responsible for 30 patents and is a technology reviewer for the National Cancer Institute, National Science Foundation, and National Institutes of Health.
The ground-breaking medical solutions of Pulse Therapeutics continues to attract investors and garner media coverage.
Transaction Name Pulse Therapeutics acquired by Euphrates VascularAcquired by Euphrates VascularAnnounced Date Jan 2019